In a successful week for the medical technology companies in the LSI Alumni community, we saw the LSI Alumni raise new funding, appoint new executives, emerge from stealth, and much more on the road to LSI Europe '24 in Sintra, Portugal (Sept 16-20).
Received a $1.1M grant funded by the Maryland Community Health Resources Commission to provide vital support to students, families, and caregivers within Howard County Public Schools. Backpack Healthcare is a leading provider of mental health services, focusing on innovative care and community partnerships to support children, teens, and families.
Closed $4.5M in a Series A2 financing, led by Morningside Ventures. The company is developing patient-specific guides using patient imaging data and state-of-the-art 3D printing technologies that are commercially available in Europe and being studied in a U.S. pivotal trial.
Announced the appointment of Dr. Jennifer Joe as Vice President, Medical Affairs. The company's Moda-flx Hemodialysis System provides clinicians the flexibility to easily customize each hemodialysis experience according to patient needs in one integrated system.
Announced the appointment of Dan Rose as Chief Executive Officer. The company's Hēlo Thrombectomy System is designed to remove clots with its patented dual-action approach that simultaneously combines the power of aspiration with advanced mechanical clot disruption.
Announced a collaborative study with Dialysis Education Services and Lifeliqe to evaluate the impact of Lifeliqe's virtual reality product on dialysis workforce training programs conducted by DES. This partnership focuses on assessing the effectiveness of VR tools in improving training outcomes, with a particular emphasis on workforce engagement, recruitment, and retention.
Emerged from stealth and announced a $4 million contract with the Department of Defense. The company's mission is to offer easy-to-use patient-safe imaging systems that aim to provide physicians with real-time imaging of all tissue types to aid in effective patient diagnostics and guidance to improve clinical outcomes and save lives regardless of environment or infrastructure
Announced the appointment of Darin Hammers as New CEO. The company is focused on developing, manufacturing, distributing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.
Selected as ‘Best Start-Up’ candidate by the Prix Galien Foundation. The company is capitalizing on the emergence of low dose CT scanning to detect early-stage lung tumors and clinical studies demonstrating that surgical removal of less tissue in early-stage lung cancer, with appropriate margins, can be curative.
Announced the appointment of Lloyd Diamond as new CEO. The company's flagship product, EndoZip™, offers a minimally invasive approach for obesity class I & II patients, ensuring consistent, safe suturing with the press of a button.
Announced the appointment of Bryan Humbarger as Chief Commercial Officer. The company is advancing surgery through a proprietary platform that synthesizes artificial intelligence, computer vision, and augmented reality.
Awarded a $160,000 seed grant from the Consortium for Technology & Innovation in Pediatrics (CTIP) Accelerator. The VP.S ENCORE® is a hypothermic machine perfusion device for prolonged cardiac graft preservation.
Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.
Schedule an exploratory call
Request Info© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
.png)
